Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2002 Oct;122(4):1264-70.
doi: 10.1378/chest.122.4.1264.

Pneumonic vs nonpneumonic acute exacerbations of COPD

David Lieberman  1 , Devora Lieberman, Yevgenia Gelfer, Raiesa Varshavsky, Bella Dvoskin, Maija Leinonen, Maureen G Friedman
Affiliations
Comparative Study

Pneumonic vs nonpneumonic acute exacerbations of COPD

David Lieberman et al. Chest. 2002 Oct.

Abstract

Study objective: To describe and compare the background, clinical manifestations, disease course, and infectious etiologies of pneumonic acute exacerbations (PNAE) vs nonpneumonic acute exacerbations (NPAE) of COPD.

Design: A prospective, observational study.

Setting: A tertiary university medical center in southern Israel.

Patients: Twenty-three hospitalizations for PNAE and 217 hospitalizations for NPAE were included in the study. Paired sera were obtained for each of the hospitalizations and were tested serologically for 12 pathogens. Only a significant change in antibody titers or levels was considered diagnostic.

Results: No significant differences were found between the two groups for any of the parameters related to COPD or comorbidity. The clinical type of the exacerbation was not significantly different between the groups. Compared to NPAE, patients with PNAE had lower PO(2) values at hospital admission (p = 0.004) but higher rates of abrupt onset (p = 0.005), ICU admissions (p = 0.006), invasive mechanical ventilation (p = 0.01), mortality (p = 0.007), and longer hospital stay (p = 0.001). In 22 PNAE hospitalizations (96%) and in 153 NPAE hospitalizations (71%), at least one infectious etiology was identified (p = 0.001). Mixed infection was found in 13 patients with PNAE (59%) and in 59 patients with NPAE (39%; not significant [NS]). Viral etiology was identified in 18 patients with PNAE (78%) compared with 99 patients with NPAE (46%; p = 0.003). Pneumococcal etiology was found in 10 patients with PNAE (43%) and in 38 patients with NPAE (18%; p = 0.006). An atypical etiology was identified in 8 patients with PNAE (35%) and 64 patients with NPAE (30%; NS).

Conclusions: Community-acquired pneumonia is common among patients hospitalized for an acute exacerbation of COPD and is generally manifested by more severe clinical and laboratory parameters. In PNAE, compared to NPAE, viral and pneumococcal etiologies are more common, but the rate of atypical pathogens is similar. The therapeutic significance of these findings should be investigated further.

PubMed Disclaimer

Comment in

References

    1. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152:S77–S120. - PubMed
    1. Anthonisen NR, Manfreda J, Warren CPW. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196–204. - PubMed
    1. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis. 1989;11:586–599. - PubMed
    1. Pachon J, Prados MD, Capote F. Severe community-acquired pneumonia: etiology, prognosis and treatment. Am Rev Respir Dis. 1990;142:369–373. - PubMed
    1. Torres A, Serra-Batlles J, Ferrer A. Severe community-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis. 1991;144:312–318. - PubMed

Publication types

MeSH terms